uniQure (QURE) Net Margin Growth (1y) (2017 - 2026)

uniQure (QURE) Net Margin Growth (1y) (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1,491.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1,120.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -653.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 447.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 uniQure 2.47 Bn 2.47 Bn 3.34 Mn 128,180.00

Historic Data

Download Data
DateValue
Mar 31, 2026 128,180.00
Dec 31, 2025 169,860.00
Sep 30, 2025 -20,557.00
Jun 30, 2025 -21,081.00
Mar 31, 2025 -201,141.00
Dec 31, 2024 -30,877.00
Sep 30, 2024 442,565.00
Jun 30, 2024 232,115.00
Mar 31, 2024 67,693.00
Dec 31, 2023 -110,105.00
Sep 30, 2023 -306,334.00
Jun 30, 2023 503,219.00
Mar 31, 2023 115,453.00
Dec 31, 2022 -760.00
Sep 30, 2022 -146,611.00
Jun 30, 2022 -794,547.00
Mar 31, 2022 654,850.00
Dec 31, 2021 1,628.00
Sep 30, 2021 116,922.00
Jun 30, 2021 285,817.00